Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Clinical trial NCT02476006 · COMPLETED
Trial details
- NCT number
- NCT02476006
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-23
- Primary completion
- 2019-04-12
- Enrollment
- 998
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.